These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 7002168)

  • 1. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
    Gragnoli G; Tanganelli I; Signorini AM
    Boll Soc Ital Biol Sper; 1980 Jan; 56(1):69-75. PubMed ID: 7002168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of insulin, C-peptide and glucagon in liver cirrhosis.
    Gragnoli G; Signorini AM; Tanganelli I
    J Endocrinol Invest; 1981; 4(1):1-5. PubMed ID: 7016966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of glucose intolerance in cirrhosis of the liver.
    Shankar TP; Solomon SS; Duckworth WC; Himmelstein S; Gray S; Jerkins T; Bobal MA; Iyer RS
    J Lab Clin Med; 1983 Oct; 102(4):459-69. PubMed ID: 6352838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behavior of C-peptide and immunoreactive insulin in essential obesity].
    Gragnoli G; Signorini AM; Tanganelli I; Martinelli G
    Boll Soc Ital Biol Sper; 1979 Mar; 55(6):564-70. PubMed ID: 399187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma lipids, insulin, C-peptide, and glucagon levels in cirrhosis: personal observations].
    Luca M; Sfogliano L; Privitera P; Noto R
    Riv Eur Sci Med Farmacol; 1989 Apr; 11(2):113-22. PubMed ID: 2678305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma glucose, insulin, proinsulin, C-peptide and glucagon before and after a carbohydrate-rich meal in hyperthyroid patients.
    Rovira A; Valdivielso L; Ortega R; Valverde I; Herrera Pombo JL
    Diabete Metab; 1987; 13(4):431-5. PubMed ID: 3315763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes.
    Hiroyoshi M; Tateishi K; Yasunami Y; Maeshiro K; Ono J; Matsuoka Y; Ikeda S
    Am J Gastroenterol; 1999 Apr; 94(4):976-81. PubMed ID: 10201468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Consequences of hyperglycemia on glucose and nitrogen metabolism in liver cirrhosis. A study using a hyperglycemic clamp].
    Vetter D; Fratte S; Winiszewski P; Reville M; Hirsch E; Roze F; Blickle JF; Pinget M; Doffoel M; Bockel R
    Gastroenterol Clin Biol; 1990; 14(5):483-91. PubMed ID: 2194890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide.
    Frier BM; Ashby JP; Nairn IM; Baird JD
    Diabete Metab; 1981 Mar; 7(1):45-9. PubMed ID: 7016620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma insulin and C-peptide levels in cirrhotic and uremic patients.
    Kawai K; Hayakawa H; Yoshida K; Shimizu M; Noto Y
    Diabete Metab; 1977 Mar; 3(1):7-10. PubMed ID: 323089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum C peptide and IRI levels after administration of glucagon and glucose in non-insulin-dependent diabetics.
    Jayyab AK; Heding LG; Czyzyk A; Malczewski B; Królewski AS
    Horm Metab Res; 1982 Mar; 14(3):112-6. PubMed ID: 7040196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral glucose in cirrhotics. Effects on plasma aminoacid patterns and the role of insulin and glucagon.
    Marchesini G; Forlani G; Angiolini A; Zoli M; Scolari MP; Bianchi FB; Pisi E
    Diabete Metab; 1979 Jun; 5(2):135-9. PubMed ID: 478083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal.
    Holst JJ; Burcharth F; Kühl C
    Diabete Metab; 1980 Jun; 6(2):117-27. PubMed ID: 6997101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-peptide pattern in patients with pancreatic cancer.
    Fogar P; Basso D; Panozzo MP; Del Favero G; Briani G; Fabris C; D'Angeli F; Meggiato T; Ferrara C; Plebani M
    Anticancer Res; 1993; 13(6B):2577-80. PubMed ID: 8135497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of plasma glucagon-like immunoreactivity (GLI) in patients with liver cirrhosis.
    Watanabe A; Hashimoto M; Higashi T; Kobayashi M; Nakatsukasa H; Yamauchi Y; Watanabe M; Fujiwara M; Nagashima H
    J Med; 1986; 17(2):95-108. PubMed ID: 3473162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose resistance contributes to diabetes mellitus in cirrhosis.
    Petrides AS; Schulze-Berge D; Vogt C; Matthews DE; Strohmeyer G
    Hepatology; 1993 Aug; 18(2):284-91. PubMed ID: 8340056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin and C-peptide secretion in non-obese patients with polycystic ovarian disease.
    Mahabeer S; Jialal I; Norman RJ; Naidoo C; Reddi K; Joubert SM
    Horm Metab Res; 1989 Sep; 21(9):502-6. PubMed ID: 2684835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation and secretion of insulin in hepatic cirrhosis.
    Iwasaki Y; Ohkubo A; Kajinuma H; Akanuma Y; Kosaka K
    J Clin Endocrinol Metab; 1978 Oct; 47(4):774-9. PubMed ID: 400732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of metformin on blood glucose, insulin and C-peptide responses to glucagon in non-insulin dependent diabetics.
    Ferlito S; Del Campo F; Di Vincenzo S; Damante G; Coco R; Branca S; Fichera C
    Farmaco Sci; 1983 Apr; 38(4):248-54. PubMed ID: 6345193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin, C-peptide and glucagon levels during OGTT in hepatic cirrhosis and in patients with prehepatic block.
    Gerö L; Korányi L; Szalay F; Büki B; Tamás G
    Acta Diabetol Lat; 1982; 19(1):55-64. PubMed ID: 7041501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.